This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Destiny Pharma Croissance future
Future contrôle des critères 0/6
Destiny Pharma's revenue and earnings are forecast to decline at 171.4% and 15.5% per annum respectively while EPS is expected to decline by 13.6% per annum.
Informations clés
-15.5%
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Biotechs croissance des bénéfices | 35.6% |
Taux de croissance des recettes | -171.4% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 15 Jul 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | N/A | -8 | N/A | N/A | 1 |
12/31/2024 | N/A | -6 | -6 | -5 | 2 |
12/31/2023 | 1 | -6 | -6 | -5 | N/A |
9/30/2023 | 1 | -6 | -5 | -5 | N/A |
6/30/2023 | 1 | -6 | -5 | -5 | N/A |
3/31/2023 | 1 | -6 | -6 | -6 | N/A |
12/31/2022 | 0 | -7 | -6 | -6 | N/A |
9/30/2022 | 0 | -6 | -5 | -5 | N/A |
6/30/2022 | 0 | -6 | -5 | -5 | N/A |
3/31/2022 | 0 | -6 | -5 | -5 | N/A |
12/31/2021 | 0 | -5 | -5 | -5 | N/A |
9/30/2021 | 0 | -5 | -7 | -6 | N/A |
6/30/2021 | 0 | -5 | -9 | -6 | N/A |
3/31/2021 | 0 | -5 | -8 | -6 | N/A |
12/31/2020 | 0 | -5 | -8 | -5 | N/A |
9/30/2020 | 0 | -5 | -6 | -5 | N/A |
6/30/2020 | 0 | -5 | -4 | -4 | N/A |
3/31/2020 | 0 | -5 | -4 | -4 | N/A |
12/31/2019 | 0 | -5 | -5 | -5 | N/A |
9/30/2019 | 0 | -5 | -5 | -5 | N/A |
6/30/2019 | N/A | -5 | -6 | -6 | N/A |
3/31/2019 | N/A | -5 | -5 | -5 | N/A |
12/31/2018 | N/A | -5 | -5 | -5 | N/A |
9/30/2018 | N/A | -5 | -4 | -4 | N/A |
6/30/2018 | N/A | -4 | -3 | -3 | N/A |
3/31/2018 | N/A | -4 | -3 | -3 | N/A |
12/31/2017 | N/A | -3 | -2 | -2 | N/A |
9/30/2017 | N/A | -2 | N/A | -2 | N/A |
6/30/2017 | N/A | -2 | N/A | -1 | N/A |
3/31/2017 | N/A | -1 | N/A | -1 | N/A |
12/31/2016 | N/A | -1 | N/A | -1 | N/A |
12/31/2015 | N/A | -1 | N/A | -1 | N/A |
12/31/2014 | N/A | -2 | N/A | -2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: D89 is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: D89 is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: D89 is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: D89 is forecast to have no revenue next year.
Croissance élevée des revenus: D89 is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if D89's Return on Equity is forecast to be high in 3 years time